
NYSE:CL
This summary was created by AI, based on 2 opinions in the last 12 months.
Colgate-Palmolive (CL) has garnered positive attention as analysts recommend buying the stock at its 52-week lows, paired with a modest 2.5% dividend yield. Despite enduring a challenging year for consumer staples, the company's latest performance has shown resilience, with CL surpassing both revenue and earnings expectations. The supply chain is showing signs of improvement, although there are lingering concerns regarding tariff-related costs, which have seen a reduction from an initial estimate of $200 million to $75 million. Analysts remain optimistic about the company's long-term prospects, highlighting its ability to navigate current market challenges while maintaining operational efficiency and profitability.